(Q42990573)

12 November 2017

title

Effectiveness of leukocyte interferon-alpha treatment in patients with chronic hepatitis C not responsive to recombinant interferon (English)

1 reference

12 November 2017

Scotto G

1

1 reference

12 November 2017

Grimaldi M

series ordinal

2

1 reference

12 November 2017

publication date

1 October 1998

1 reference

Digestive Diseases and Sciences

12 November 2017

published in

1 reference

12 November 2017

volume

43

1 reference

12 November 2017

issue

10

1 reference

12 November 2017

page(s)

2173-2176

1 reference

Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection

12 November 2017

cites work

1 reference

12 December 2020

Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon

1 reference

12 December 2020

Lymphoblastoid alpha-interferon for chronic hepatitis C: a randomized controlled study

1 reference

12 December 2020

Interferon alpha-2b treatment of chronic posttransfusion non-A, non-B/C hepatitis: long-term outcome and effect of increased interferon doses in non-responders

1 reference

12 December 2020

Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylaxis of high-risk pre-cancerous conditions

1 reference

12 December 2020

A pilot study of ribavirin therapy for chronic hepatitis C

1 reference

12 December 2020

Short and long-term effects of interferon on serum markers of hepatitis C virus replication

1 reference

12 December 2020

Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations

1 reference

12 December 2020

Human leucocyte interferon-alpha therapy can induce a second response in treatment of thrombocytosis in patients with neutralising antibodies to recombinant interferon-alfa 2a

1 reference

12 December 2020

Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis

1 reference

12 December 2020

Comparison of the Antiviral Activities of Various Cloned Human Interferon- Subtypes in Mammalian Cell Cultures

1 reference

12 December 2020

Treatment of anti-recombinant interferon-alpha 2 antibody positive CML patients with natural interferon-alpha

1 reference

12 December 2020

Interferon-alpha retreatment in chronic hepatitis C

1 reference

12 December 2020

Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia

1 reference

12 December 2020

Re-treatment of interferon-resistant patients with chronic hepatitis C with interferon-alpha

1 reference

12 December 2020

[The interferon treatment of chronic hepatitis C. Short- and long-term therapy and the problem of nonresponders]

1 reference

12 December 2020

Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C

1 reference

12 December 2020

Effective natural interferon-alpha therapy in recombinant interferon-alpha-resistant patients with hairy cell leukemia

1 reference

12 December 2020

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

1 reference

12 December 2020

Clinical significance of anti-IFN-alpha antibody titres during interferon therapy

1 reference

12 December 2020

Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells

1 reference

12 December 2020

Natural course of chronic hepatitis C

1 reference

12 December 2020

The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1026693901012

1 reference

Dimensions Publication ID

12 November 2017

1033671144

0 references

1 reference